kt 6149 has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Ashizawa, T; Gomi, K; Kasai, M; Kobayashi, S; Okabe, M; Okamoto, A; Saito, H | 1 |
| Ashizawa, T; Kasai, M; Kono, M; Morimoto, M; Saitoh, Y; Sato, A; Shirahata, K | 1 |
2 other study(ies) available for kt 6149 and Sarcoma 180
| Article | Year |
|---|---|
Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Survival; HeLa Cells; Humans; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Sarcoma 180; Tumor Cells, Cultured | 1995 |
Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Leukemia P388; Mice; Mice, Inbred Strains; Mitomycins; Sarcoma 180 | 1989 |